Skip to content

Observational Study of How Patients Take Eye Drops

The Relationship Between Glaucoma Medication Self-Efficacy, Outcome Expectations, Eye Drop Tech., Adherence and IOP.

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00750646
Enrollment
220
Registered
2008-09-10
Start date
2008-09-30
Completion date
2009-08-31
Last updated
2008-09-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glaucoma

Keywords

compliance, eye drop administration, MEMS, adherence

Brief summary

This study is interested in monitoring how patients take eye drops, both through video-recordings and adherence monitoring, as well as their perceptions about their eye medications; including the dosing schedules, instillation techniques and effect on their disease.

Interventions

DEVICEMEMS cap

The Medication Event Monitoring System will be used to assess the level of subject adherence to recommended topical eye drop therapy.

Sponsors

Alcon Research
CollaboratorINDUSTRY
Robin, Alan L., M.D.
Lead SponsorINDIV

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* \>18 year old * currently taking 1 or more hypotensive topical eye drops takes drops in the right eye for more than 6 months expect to continue drop use for the next 3 months * subjects instill their own eye drops * subject is able to take HVF tests * subject will expect to complete the 3 months enrollment period

Exclusion criteria

* unable/unwilling to instill own medications * eye drops are discontinued * unable to take HVF test * unable to complete follow-up * investigators discontinue subject for safety reasons * not using drops in left eye

Design outcomes

Primary

MeasureTime frame
Medication adherence measured by MEMS caps3 months
Eye drop technique measured by video evaluation1 time observation

Secondary

MeasureTime frame
Medication adherence measured by self-report3 months
Severity of VF damage1 test date
Intraocular pressure readings3 months

Countries

United States

Contacts

Primary ContactJennifer L Stone, OD
jstone@glacuomaexpert.com410 377 2422
Backup ContactColleen K Protzko
cprotzko@glaucomaexpert.com4103772422

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026